{"disease":{"id":"relapsed-refractory-b-cell-neoplasms","name":"relapsed refractory b cell neoplasms"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07200479","title":"A Clinical Study to Explore CT1194D in Patients With Relapsed/Refractory B-Cell Neoplasms","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":20,"lead_sponsor_name":"Institute of Hematology & Blood Diseases Hospital, China","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}